Skip to content

When the Clot Thickens: Management of Venous Thromboembolism

This activity is intended for hospital-based pharmacists focused in the area of treating venous thromboembolism (VTE) patients, including special patient populations.

Venous thromboembolism (VTE) is a prevalent disease state in the United States that carries high risk of morbidity and mortality. As more data is published regarding the use of direct oral anticoagulants (DOACs) in VTE and in special patient populations, such as patients with malignancy, the recommendations around suggested VTE treatment will continue to be updated. The American Society of Hematology (ASH) recently updated their VTE treatment guidelines (2020) and their management of VTE in cancer guidelines (2021). This module provides and opportunity to apply the most current guidelines to special population cases.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Explain recommendations regarding VTE management from previous guidelines to those from the most current guidelines.
  • Describe an appropriate treatment plan for a patient with VTE.
  • Identify treatment recommendations for various special patient populations, including recommendations in pregnancy and patients with cancer.


Hannah Ritchie, PharmD is a PGY1 Pharmacy Resident at Baystate Medical Center in Springfield, Massachusetts. Hannah is originally from Santa Clarita, California and earned her Doctor of Pharmacy degree in May 2020 from the University of Rhode Island. Hannah’s primary interest areas include Critical Care, Emergency Medicine, and Academia. Hannah has early committed to the PGY2 Critical Care Pharmacy Residency at Baystate Medical Center for 2021-2022. Hannah is looking forward to a career of providing the utmost care for patients, contributing to the medical team, lifelong learning, and teaching others!

Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.


ACPE logo

Release Date: June 9, 2021
Expiration Date: June 9, 2022
Contact Hours: 1 (.10 CEU)
Universal Activity Number: 0026-0000-21-134-H04-P | Application-based
ACPE Topic Designator: General Pharmacy


Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-test, and evaluation. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

It is the policy of MCPHS-CE to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals engaged in the planning of a continuing education activity and who are in a position to control the educational content are required to disclose any financial relationships with ineligible companies occurring within the past 24 months. The intent of this policy is to identify and mitigate any potential conflict of interest that may directly or indirectly affect the activity. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

MCPHS will identify, review and mitigate all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

No funding from industry provided for this event. No exhibitors will be present.
Hannah Ritchie and MCPHS CE staff members hold no financial relationships with ineligible companies, related to the content of this presentation